Quality of life, mood disturbances and psychological parameters in adult patients with GH deficiency

Panminerva Medica

Volumn 54, Issue 4, 2012, Pages 323-331

  Prodam, F ^a   Caputo, M ^a   Belcastro, S ^a   Garbaccio, V ^a   Zavattaro, M ^a   Sama M T ^a   Bellone, S ^a   Pagano, L ^a   Bona, G ^a   Aimaretti, G ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Hypopituitarism; Mental disorders; Quality of life

Indexed keywords

BIOLOGICAL MARKER; HUMAN GROWTH HORMONE;

ADULT; AFFECT; ARTICLE; BLOOD; COGNITION; GROWTH DISORDER; HUMAN; HYPOPITUITARISM; MENTAL HEALTH; PROGNOSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RISK FACTOR;

ADULT; AFFECT; BIOLOGICAL MARKERS; COGNITION; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; MENTAL HEALTH; PROGNOSIS; QUALITY OF LIFE; RISK FACTORS;

EID: 84871568649     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Cook DM, Ludlam WH, Cook MB. The adult growth hormone deficiency syndrome. Adv Intern Med 2000; 45: 297-315.
2. Hoffman AR. Treatment of the adult growth hormone deficiency syndrome: Directions for future research. Growth Horm IGF Res 2005; 15( Suppl A): 48-52.
3. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML; Endocrine society. evaluation and treatment of adult growth hormone deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1587-609.
4. Rosén T, Wirén L, Wilhelmsen L, Wiklund I, Bengtsson BA. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol 1994;40:111-6. (Pubitemid 24193136)
5. Ross JL. Effects of growth hormone on cognitive function. Horm Res 2005;64(Suppl 3):89-94. (Pubitemid 43163318)
6. Zenker S, Haverkamp F, Klingmuller D. Growth hormone deficiency in pituitary disease: relationship to depression, apathy and somatic complaints. Eur J Endocrinol 2002; 147: 165-71.
7. Wallymahmed M, Foy P, MacFarlane I. The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects. Clin Endocrinol 1999;51:333-8. (Pubitemid 29439053)
8. Peace KA, Orme SM, Sebastian JP, Thompson AR, Barnes S, Ellis A et al. The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease. Clin Endocrinol 1997;46:445-50. (Pubitemid 27242680)
9. Deijen J, de Boer H, van der Veen E. Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology 1996; 23: 45-55.
10. Giusti M, Meineri I, Malagamba D, Cuttica CM, Fattacciu G, Menichini U et al. Impact of recombinant human growth hormone treatment on psychological profiles in hypopituitary patients with adultonset growth hormone deficiency. Eur J Clin Invest 1998;28:13-9. (Pubitemid 28062474)
11. Baum HB, Katznelson L, Sherman JC, Biller BM, Hayden DL, Schoenfeld DA et al. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adultonset GH deficiency. J Clin Endocrinol Metab 1998;83:3184-9. (Pubitemid 28500954)
12. Arwert LI, Deijen JB, Müller M, Drent ML. Long-term growth hormone treatment preserves GH-induced memory and mood improvements: a 10-year follow-up study in GH-deficient adult men. Horm Behav 2005;47:343-9. (Pubitemid 40222742)
13. Attanasio AF, Shavrikova EP, Blum WF, Shalet SM. Quality of life in childhood onset growth hormone-deficient patients in the transition phase from childhood to adulthood. J Clin Endocrinol Metab 2005;90:4525-9. (Pubitemid 41159337)
14. Lasaite L, Bunevicius R, Lasiene D, Lasas L. Psychological functioning after growth hormone therapy in adult growth hormone deficient patients: Endocrine and body composition correlates. Medicina (Kaunas) 2004; 40: 740-4.
15. Van Nieuwpoort IC, Drent ML. Cognition in the adult with childhood-onset GH deficiency. Eur J Endocrinol 2008; 159: S53-7.
16. McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L et al. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res 1999;8:373-83. (Pubitemid 29369642)
17. Schneider HJ, Schneider M, Saller B, Petersenn S, Uhr M, Husemann B et al. Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur J Endocrinol 2006; 154: 259-65.
18. Aimaretti G, Ghigo E. Should every patient with traumatic brain injury be referred to an endocrinologist? Nat Clin Pract Endocrinol Metab 2007;3:318-9. (Pubitemid 46474655)
19. Bushnik T, Englander J, Katznelson L. Fatigue after TBI: association with neuroendocrine abnormalities. Brain Inj 2007;21:559-66. (Pubitemid 46993181)
20. Klose M, Watt T, Brennum J, Feldt-Rasmussen U. Posttraumatic hypopituitarism is associated with an unfavorable body composition and lipid profile, and decreased quality of life 12 months after injury. J Clin Endocrinol Metab 2007; 92: 3861-80.
21. Corneli G, Amaretti G, Ghigo E. Managing patients with hypopituitarism after traumatic brain injury. Curr Opin Endocrinol Diabetes Obes 2007;14:301-5. (Pubitemid 47067115)
22. Aleman A, Verhaar HJ, De Haan EH, De Vries WR, Samson MM, Drent ML et al. Insulin-like growth factor-I and cognitive function in healthy older men. J Clin Endocrinol Metab 1999;84:471-5. (Pubitemid 29075671)
23. Van Dam PS, Aleman A, de Vries WR, Deijen JB, van der Veen EA, de Haan EH et al. Growth hormone, insulin-like growth factor I and cognitive function in adults. Growth Horm IGF Res 2000;10(Suppl B):S69-S73. (Pubitemid 30637220)
24. Harvey S, Hull K. Neural growth hormone: An update. J Mol Neurosci 2003; 20: 1-14.
25. Lai ZN, Emtner M, Roos P, Nyberg F. Characterization of putative growth hormone receptors in human choroid plexus. Brain Res 1991; 546: 222.
26. Johansson JO, Larson G, Andersson M, Elmgren A, Hynsjö L, Lindahl A et al. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology 1995; 61: 57-66.
27. Popovic V. GH Deficiency as the most common pituitary defect after TBI: Clinical implications. Pituitary 2006; 8: 239-43.
28. Zitzmann M, Nieschlag E. Testosterone levels in healthy men and the relation to behavioural and physical characteristics: facts and constructs. Eur J Endocrinol 2001;144:183-97. (Pubitemid 32266285)
29. Fink G, Sumner BE, Rosie R, Grace O, Quinn JP. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 1996;16:325-44. (Pubitemid 26231262)
30. Donovan BT. The behavioural actions of the hypothalamic peptides: a review. Psychol Med 1978; 8: 305-6.
31. González-Clemente JM, Halperín I, Navarro MP, Conget JI, Martínez-Osaba MJ, Vilardell E. Isolated ACTH deficiency. Med Clin 1994; 102: 220-4.
32. Kawai K, Tamai H, Nishikata H, Kobayashi N, Matsubayashi S. Severe depression associated with ACTH, PRL, and GH deficiency: a case report. Endocr J 1994;41:275-9. (Pubitemid 24237306)
33. Wolkowitz OM, Tinklenberg JR, Wiengartner H. A psychopharmacological perspective of cognitive functions. II. Specific pharmacologic agents. Neuropsychobiology 1985;14:133-56. (Pubitemid 16154551)
34. Cuneo RC, Salomon F, McGauley GA, Sönksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol 1992; 37: 387-97.
35. De Boer H, Blok GJ, van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1996; 16: 63-86.
36. Johannsson G, Bengtsson BA, Andersson B, Isgaard J, Caidahl K. Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients. Clin Endocrinol 1996;45:305-14. (Pubitemid 26306699)
37. Quik EH, Conemans EB, Valk GD, Kenemans JL, Koppeschaar HP, Dam PS. Cognitive performance in older males is associated with growth hormone secretion. Neurobiol Aging 2010; 17.
38. Quik EH, van Dam PS, Kenemans JL. Growth hormone and selective attention: A review. Neurosci Biobehav Rev 2010; 34: 1137-43.
39. Copinschi G, Nedeltcheva A, Leproult R, Morselli LL, Spiegel K, Martino E et al. Sleep disturbances, daytime sleepiness, and quality of life in adults with growth hormone deficiency. J Clin Endocrinol Metab 2010; 95: 2195-202.
40. Rollero A, Murialdo G, Fonzi S, Garrone S, Gianelli MV, Gazzerro E et al. Relationship between cognitive function, growth hormone and insulin-like growth factor I plasma levels in aged subjects. Neuropsychobiology 1998;38:73-9. (Pubitemid 28414290)
41. Alemán A, de Vries WR, de Haan EH, Verhaar HJ, Samson MM, Koppeschaar HP. Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men. Neuropsychobiology 2000;1:73-8. (Pubitemid 30058127)
42. Dean HJ, McTaggart TL, Fish DG, Friesen HG. The educational, vocational, and marital status of growth hormone-deficient adults treated with growth hormone during childhood. Am J Dis Child 1985;139:1105-10. (Pubitemid 16258036)
43. Stabler B, Turner JR, Girdler SS, Light KC, Underwood LE. Reactivity to stress and psychological adjustment in adults with pituitary insufficiency. Clin Endocrinol 1992; 36: 467-73.
44. Bülow B, Hagmar L, Ørbaek P, Osterberg K, Erfurth EM. High incidence of mental disorders, reduced mental well-being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease. Clin Endocrinol 2002;56:183-93. (Pubitemid 34234799)
45. Arwert LI, Veltman DJ, Deijen JB, van Dam PS, Delemarre-van deWaal HA, Drent ML. Growth hormone deficiency and memory functioning in adults visualized by functional magnetic resonance imaging. Neuroendocrinology 2005;82:32-40. (Pubitemid 43152792)
46. Arwert LI, Veltman DJ, Deijen JB, van Dam PS, Drent ML. Effects of growth hormone substitution therapy on cognitive functioning in growth hormone deficient patients: a functional MRI study. Neuroendocrinology 2006;83:12-9. (Pubitemid 43877917)
47. Lijffijt M, Van Dam PS, Kenemans JL, Koppeschaar HP, de Vries WR, Drent ML et al. Somatotropic-axis deficiency affects brain substrates of selective attention in childhood-onset growth hormone deficient patients. Neurosci Lett 2003;353:123-6. (Pubitemid 37510196)
48. Urban RJ. Hypopituitarism after acute brain injury. Growth Horm IGF Res 2006; 16. S25-S9.
49. Agha A, Thompson CJ. Anterior pituitary dysfunction following traumatic brain injury (TBI). Clin Endocrinol 2006; 64: 481-8.
50. Sterr A, Herron KA, Hayward C, Montaldi D. Are mild head injuries as mild as we think? Neurobehavioral concomitants of chronic post-concussion syndrome. BMC Neurol 2006; 6: 7.
51. Kay T, Harrington DE, Adams R. Definition of mild traumatic brain injury. J Head Trauma Rehabil 1993;8:86-7. (Pubitemid 23270997)
52. Gowda NK, Agrawal D, Bal C, Chandrashekar N, Tripati M, Bandopadhyaya GP et al. Technetium Tc-99m ethil cysteinate dimer brain single-photon emission CT in mild traumatic brain injury: a prospective study. Am J Neuroradiol 2006;27:447-51. (Pubitemid 44897859)
53. Gururaj G. Epidemiology of traumatic brain injuries: Indian scenario. Neurol Res 2002;24:24-8. (Pubitemid 34038394)
54. Binder LM, Rohling ML, Larrabee J. A review of mild head trauma. Part I: Meta-analytic review of neuropsychological studies. J Clin Exp Neuropsychol 1997;19:421-31. (Pubitemid 27316173)
55. Alexander MP. Mild traumatic brain injury: pathophysiology, natural history, and clinical management. Neurology 1995; 45: 1253-60.
56. Hughes DG, Jackson A, Mason DL, Berry E, Hollis S, Yates DW. Abnormalities on magnetic resonance imaging seen acutely following mild traumatic brain injury: correlation with neuropsychological tests and delayed recovery. Neuroradiology 2004;46:550-8. (Pubitemid 39144789)
57. Carroll LJ, Cassidy JD, Peloso PM, Borg J, von Holst H, Holm L et al. Prognosis for mild traumatic brain injury: results of the WHO Collaboring Centre Task Force on Mild Traumatic Brain Injury. J Rehabil Med 2004;(43 Suppl):84-105. (Pubitemid 38268224)
58. Stalnacke BM, Elgh E, Sojka P. One-year follow-up of mild traumatic brain injury: cognition, disability and life satisfaction of patients seeking consultation. J Rehabil Med 2007; 39: 404-11.
59. Jacobson RR. The post-concussional syndrome: physiogenesis, psychogenesis and malingering. An integrative model. J Pschosom Res 1995; 39: 675-93.
60. Bryant RA. Posttraumatic stress disorder and mild brain injury: controversies, causes and consequences. J Clin Exp Neuropsychol 2001;23:718-28. (Pubitemid 33817409)
61. Korn A, Golan H, Melamed I, Pascual-Marqui R, Friedman A. Focal cortical dysfunction and blood-brain barrier disruption in patients with postconcussion syndrome. J Clin Neurophysiol 2005; 22: 1-10.
62. Kurca E, Sivak S, Kulcera P. Impaired cognitive functions in mild traumatic brain injury patients with normal and pathological magnetic resonance imaging. Neuroradiology 2006;48:661-9. (Pubitemid 44355777)
63. Hofman PA, Stapert SZ, van Kroonenburgh MJ, Jolies J, de Kruijk J, Wilmink JT. MR imaging, single-photon emission CT, and neurocognitive performance after mild traumatic brain injury. Am J Neuroradiol 2001;22:441-9. (Pubitemid 32221406)
64. Paterakis K, Karantanas AH, Komnos A, Volikas Z. Outcome of patients with diffuse axonal injury: the significance and prognostic value of MRI in the acute phase. J Trauma 2000;49:1071-5. (Pubitemid 32051851)
65. Kornblum RN, Fisher RS. Pituitary lesions in craniocerebral injuries. Arch Pathol 1969; 88: 242-8.
66. Sathiavageeswaran M, Burnam P, Lawrance D. Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo controlled 12-month study. Eur J Endocrinol 2001; 56: 439-47.
67. Marie NP, Doknic M, Pavlovic D, Pekic S, Stojanovic M, Jasovic-Gasic MP et al. Psychiatric and neuropsychological changes in growth hormone-deficient patients after traumatic brain injury in response to growth hormone therapy. J Endocrinol Invest 2010; 33: 770-5.
68. Pavlovic D, Pekic S, Stojanovic M, Zivkovic V, Djurovic B, Jovanovic V et al. Chronic cognitive sequelae after traumatic brain injury are not related to growth hormone deficiency in adults. Eur J Neurol 2010; 17: 696-702
69. High WM Jr, Briones-Galang M, Clark JA, Gilkison C, Mossberg KA, Zgaljardic DJ et al. Effect of growth hormone replacement therapy on cognition after traumatic brain injury. J Neurotrauma 2010; 27: 1565-75.